189 related articles for article (PubMed ID: 9233787)
1. Crystal structure of a pair of follistatin-like and EF-hand calcium-binding domains in BM-40.
Hohenester E; Maurer P; Timpl R
EMBO J; 1997 Jul; 16(13):3778-86. PubMed ID: 9233787
[TBL] [Abstract][Full Text] [Related]
2. The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV.
Maurer P; Hohenadl C; Hohenester E; Göhring W; Timpl R; Engel J
J Mol Biol; 1995 Oct; 253(2):347-57. PubMed ID: 7563094
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
Chlenski A; Liu S; Baker LJ; Yang Q; Tian Y; Salwen HR; Cohn SL
Cancer Res; 2004 Oct; 64(20):7420-5. PubMed ID: 15492265
[TBL] [Abstract][Full Text] [Related]
4. Changes in calcium and collagen IV binding caused by mutations in the EF hand and other domains of extracellular matrix protein BM-40 (SPARC, osteonectin).
Pottgiesser J; Maurer P; Mayer U; Nischt R; Mann K; Timpl R; Krieg T; Engel J
J Mol Biol; 1994 May; 238(4):563-74. PubMed ID: 8176746
[TBL] [Abstract][Full Text] [Related]
5. SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca(2+)-binding EF-hand.
Murphy-Ullrich JE; Lane TF; Pallero MA; Sage EH
J Cell Biochem; 1995 Feb; 57(2):341-50. PubMed ID: 7539008
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence.
Sage EH; Bassuk JA; Yost JC; Folkman MJ; Lane TF
J Cell Biochem; 1995 Jan; 57(1):127-40. PubMed ID: 7721952
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin.
Sasaki T; Hohenester E; Göhring W; Timpl R
EMBO J; 1998 Mar; 17(6):1625-34. PubMed ID: 9501084
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of human grancalcin, a member of the penta-EF-hand protein family.
Jia J; Han Q; Borregaard N; Lollike K; Cygler M
J Mol Biol; 2000 Jul; 300(5):1271-81. PubMed ID: 10903868
[TBL] [Abstract][Full Text] [Related]
9. Porcine SPARC: isolation from dentin, cDNA sequence, and computer model.
Chun YH; Yamakoshi Y; Kim JW; Iwata T; Hu JC; Simmer JP
Eur J Oral Sci; 2006 May; 114 Suppl 1():78-85; discussion 93-5, 379-80. PubMed ID: 16674666
[TBL] [Abstract][Full Text] [Related]
10. The C-terminal Ca2+-binding domain of SPARC confers anti-spreading activity to human urothelial cells.
Delostrinos CF; Hudson AE; Feng WC; Kosman J; Bassuk JA
J Cell Physiol; 2006 Jan; 206(1):211-20. PubMed ID: 16121393
[TBL] [Abstract][Full Text] [Related]
11. Crystal-structure and biochemical characterization of recombinant human calcyphosine delineates a novel EF-hand-containing protein family.
Dong H; Li X; Lou Z; Xu X; Su D; Zhou X; Zhou W; Bartlam M; Rao Z
J Mol Biol; 2008 Nov; 383(3):455-64. PubMed ID: 18775726
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
Kemball-Cook G; Johnson DJ; Tuddenham EG; Harlos K
J Struct Biol; 1999 Oct; 127(3):213-23. PubMed ID: 10544046
[TBL] [Abstract][Full Text] [Related]
13. The crystal structure of bikunin from the inter-alpha-inhibitor complex: a serine protease inhibitor with two Kunitz domains.
Xu Y; Carr PD; Guss JM; Ollis DL
J Mol Biol; 1998 Mar; 276(5):955-66. PubMed ID: 9566199
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of coagulation factor IX-binding protein from habu snake venom at 2.6 A: implication of central loop swapping based on deletion in the linker region.
Mizuno H; Fujimoto Z; Koizumi M; Kano H; Atoda H; Morita T
J Mol Biol; 1999 May; 289(1):103-12. PubMed ID: 10339409
[TBL] [Abstract][Full Text] [Related]
15. The crystal structure of the sorcin calcium binding domain provides a model of Ca2+-dependent processes in the full-length protein.
Ilari A; Johnson KA; Nastopoulos V; Verzili D; Zamparelli C; Colotti G; Tsernoglou D; Chiancone E
J Mol Biol; 2002 Mar; 317(3):447-58. PubMed ID: 11922676
[TBL] [Abstract][Full Text] [Related]
16. The laminin-binding domain of agrin is structurally related to N-TIMP-1.
Stetefeld J; Jenny M; Schulthess T; Landwehr R; Schumacher B; Frank S; Rüegg MA; Engel J; Kammerer RA
Nat Struct Biol; 2001 Aug; 8(8):705-9. PubMed ID: 11473262
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the N-terminal EGF-like domain from human factor VII.
Muranyi A; Finn BE; Gippert GP; Forsén S; Stenflo J; Drakenberg T
Biochemistry; 1998 Jul; 37(30):10605-15. PubMed ID: 9692950
[TBL] [Abstract][Full Text] [Related]
18. The N-terminal domain of human centrin 2 has a closed structure, binds calcium with a very low affinity, and plays a role in the protein self-assembly.
Yang A; Miron S; Duchambon P; Assairi L; Blouquit Y; Craescu CT
Biochemistry; 2006 Jan; 45(3):880-9. PubMed ID: 16411764
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional study of an Anemonia elastase inhibitor, a "nonclassical" Kazal-type inhibitor from Anemonia sulcata.
Hemmi H; Kumazaki T; Yoshizawa-Kumagaye K; Nishiuchi Y; Yoshida T; Ohkubo T; Kobayashi Y
Biochemistry; 2005 Jul; 44(28):9626-36. PubMed ID: 16008348
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of the epidermal growth factor (EGF)-like module of human complement protease C1r, an atypical member of the EGF family.
Bersch B; Hernandez JF; Marion D; Arlaud GJ
Biochemistry; 1998 Feb; 37(5):1204-14. PubMed ID: 9477945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
